Sprzezone dieny kwasu linolowego i ich znaczenie w patofizjologii

• Autorzy: Panczenko-Kresowska B , Ziemlanski S.

Warianty tytułu

EN

Conjugated linoleic acid and their pathophysiological importance

• Języki publikacji: PL

Słowa kluczowe

PL

dieny kwasu linolowego; sprzezone dieny kwasu linolowego; patofizjologia; dzialanie przeciwnowotworowe; dzialanie przeciwutleniajace; metabolizm lipidow; krew; lipidy; miazdzyca; choroby czlowieka

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2001
• Tom: 28
• Numer: 1
• Opis fizyczny: s.61-70,tab.,bibliogr.

Twórcy

autor

Panczenko-Kresowska B

• Zaklad Fizjologii i Biochemii Zywienia, Instytut Zywnosci i Zywienia w Warszawie, Warszawa

autor

Ziemlanski S.

Bibliografia

• 1. Banni S., Angioni E., Casu V., et al.: Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. Carcinogenessis 1999, 20, 1019-24.
• 2. Banni S., Martin J.: Conjugated linoleic acid and metabolites. In: Trans fatty acids in human nutrition. Ed. J.K. Sebedis, The Oily Press Ltd. Scotland, 1998, p. 261-302.
• 3. Bartnikowska E., Obiedziński M., Grześkowiak S.: Rola i znaczenie żywieniowe sprzężonych dienów kwasu linolowego. Przem. Spoż. 1999, 7, 16-18.
• 4. Basu S., Smedman A., Vessby B.: Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Letters 2000, 468, 33-36.
• 5. Belury M., Kempa-Steczko A.: Conjugated linoleic acid modulates hepatic lipid composition in mice. Lipids 1997, 32, 199-204.
• 6. Britton M., Fong C., Wickens D., et al.: Diet as a source of phospholipid esterified 9,11-octadecadienoic acid in humans. Clin. Sci., 1992, 83, 97-101.
• 7. Cantwell H., Devery R., Oshea M., et al.: The effect of conjugated linoleic acid on the antioxidant enzyme defense system in rat hepatocytes. Lipid 1999, 34, 833-9.
• 8. Cawood P., Wickens D., Iversen S., et al: The nature of diene conjugation in human serum, bile and duodenal juice. FEBS Lett., 1983, 162, 239-43.
• 9. Cesano A., Visonneau S., Scimeca J., et al.: Opposite effect of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res., 1998, 18, 1429-34.
• 10. Chin S., Liu W., Storkson J., et al.: Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Compos. Anal., 1992, 5, 185-197.
• 11. Cunningham D., Harrison L., Shultz T.: Proliferative responses of normal human mammary and MCF-7 breast cancer cells to linolic acid, conjugated linoleic acid and eicosanoid synthesis inhibitors in culture. Anticancer Res., 1997, 17, 197-203.
• 12. DeLany J., Blohm F., Truett A., et al.: Conjugated linoleic acid rapidlly reduces body fat content in mice without effecting energi intake. Am. J. Physiol., 1999, 276, 1172-79.
• 13. Dhar P., Ghosh S., Bhattacharyya D.: Dietary effects of conjugated octadecatrienoic fatty acid (9cis, 11trans, 13trans) levels on blood lipids and nonenzymatic in vitro lipid peroxydation in rats. Lipids 1999, 34, 109-14.
• 14. Fogerty A., Ford G., Svoronos D.: Octadeca-9,11-dienoic acid in foodstuffs and in the lipids of human blood and brest milk. Nutr. Rep. Int., 1988, 38, 937-44.
• 15. Gaviano V., Gaviano G., Leblanc M., et al.: An isomeric mixture of conjugated linoleic acids but not pure cis-9-trans-11-octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J. Nutr., 2000, 130, 27-9.
• 16. Gaviano V., Scalzo G., Tuchweber B.: Effect of short-term feeding of conjugated linoleic acid (CLA) on serum cholesterol and atherosclerosis development in hamster. FASEB J., 1998, 12, A535.
• 17. Goodwin J., Webb D.: Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol., 1980, 15, 106-12.
• 18. Ha Y., Storkson J., Pariza M.: Inhibition of benzo(a)pyrene - induced mouse forestomach neoplasia by conjugated dineoic derivatives of linoleic acid. Cancer Res., 1990, 50, 1097-1101.
• 19. Ha Y., Grimm N., Pariza M.: Anticarcinogenes from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis 1987, 8, 1881-87.
• 20. Ha Y., Grimm N., Pariza M.: Newly recognized anticarcinogenic fatty acids: identification and quantification in natural and processed cheeses. J. Agric. Food Chem., 1989, 37, 75-84.
• 21. Hayek M., Han Sung Nin., Wu D., et al.: Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrIBR mice. J. Nutr., 1999, 129, 32-8.
• 22. Houseknecht K., Van den Heuvel J., Moya-Camarena S.: Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun., 1998, 244, 678-82.
• 23. Huang Y., Luedecke L., Shultz T.: Effect of cheddar cheese consumption on plasma conjugated linoleic acid concentrations in men. FASEB J., 1994, 8, A719.
• 24. Hubbard N., Lim D., Summers L., Erickson K.: Reduction of murine mammary tumor metastasis by conjugated linoleic acid. Cancer Letters 2000, 150, 93-100.
• 25. Ip C., Banni S., Angioni E., et al.: Conjugated linoleic acid - enriched butter fat alters mamary gland morphogenesis and reduces cancer risk in rats. J. Nutr., 1999, 129, 2135-42.
• 26. Ip C., Briggs S., Haegale A., et al.: The efficacy of conjugated linoleic acid in mammary cancer prevention is independent of the level or type of fat in the diet. Carcinogenesis 1996, 17, 1045-50.
• 27. Ip C., Chin S., Scimeca J., et al.: Mammary cancer prevention by a conjugated dienoic derivative of linoleic acid. Cancer Res., 1991, 51, 118-24.
• 28. Ip C., Singh M., Thompson H., et al.: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res., 1994, 54, 1212-15.
• 29. Ip M., Masso-Welch E., Shoemaker S., et al.: Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp. Cell Res., 1999, 250, 22-39.
• 30. Iversen S., Cawood P., Madigan J., et al.: A dieneconjugated isomer of linoleic acid 18:2(9,11) in human plasma phospholipids. Life. Chem. Resp., 1985, 3, 45-48.
• 31. Jiang J., Bjorck L., Fonden R.: Conjugated linoleic acid in Swedish dairy products with special reference to manufacturing of hard cheeses. Int. Dairy J., 1997, 7, 863-7.
• 32. Jiang J., Wolk A., Vessby B.: Relation between the intake of milk fat and the occurrence of conjugated linoleic acid in human adipose tissue. Am. J. Clin. Nutr., 1999, 70, 21-7.
• 33. Kavanaugh K., Liu K., Belury M.: Effect of dietary conjugated linoleic acid on phorbol ester-induced PGE2 production on hyperplasia in mouse epidermis. Nutr. Cancer 1999, 33, 132-38.
• 34. Lee K., Kritchevsky D., Pariza M.: Conjugated linoleic acid and atherosclerosis in rabits. Atherosclerosis 1994, 108, 19-25.
• 35. Liu K., Belury M.: Conjugated linoleic acid modulation of phorbol ester-induced events in murine keratinocytes. Lipids 1997, 32, 725-30.
• 36. Meydani S., Barklund M., Liu S., et al.: Vitamin E supplementation enhances cell-mediaed immunity in healthy elderly subjects. Am. J. Clin. Nutr., 1990, 52, 557-63.
• 37. Michal J., Chew B., Schultz T., et al.: Interaction of conjugated dienoic derivatives of linoleic acid with β-carotene on cellular host defene. FASEB J., 1992, 6, A1102.
• 38. Morris N., Marr J., Clayton D.: Diet and heart: a postscrit. Br. Med. J., 1977, 2, 1307-14.
• 39. Moya-Camarena S., Belury M.: Species differences in the metabolism and regulation of gene expresion by conjugated linoleic acid. Nutr. Rev., 1999, 57, 336-340.
• 40. Munday J., Thompson K., James K.: Dietary conjugated linoleicc acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model. Br. J. Nutr., 1999, 81, 251-55.
• 41. Nicolosi R., Rogers E., Kritchevsky D., et al.: Dietary conjugated linoleic acid reduces plasma lipoproteins and early atherosclerosis in hypercholesterolemic hamsters. Artery 1997, 22, 266-77.
• 42. Ntambi J.: Prostaglandin F2α is a potent inhibitor of 3T3-L1 preadipocyte differentiation. FASEB J., 1998, 12, A515.
• 43. Pariza M., Ha Y.: Conjugated dienoic derivatives of linoleic acid: a new class of anticarcinogens. Med. Oncol. Tumor Pharmacother., 1990, 7, 169-171.
• 44. Pariza M., Ha Y., Benjamin H., et al.: Formation and action of anticarcinogenic fatty acids in nutritional and toxicological consequences of food processing. Adv. Exp. Med. Biol., 1991, 289, 269-72.
• 45. Pariza M., Park Y., Cook M., et al.: Conjugated linoleic acid reduces body fat. FASEB J. 1996, A560.
• 46. Pariza M., Park Y., Cook M.: Conjugated linoleic acid and the control of cancer and obesity. Toxicol. Sci., 1999, 52, 107-10.
• 47. Park Y., Albright K., Storkson J., et al.: Changes in body composition in mice during feeding and with drawal of conjugated linoleic acid, Lipids 1999, 34, 243-48.
• 48. Rudel L., Johnson F., Sawyer J., et al.: Dietary polyunsaturated fat modified low density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsivenes. Am. J. Clin. Nutr., 1995, 62, Suppl. 463-70S.
• 49. Rudel L.: Atherosclerosis and conjugate linoleic acid. Br. J. Nutr., 1999, 81, 177-79.
• 50. Sakono M., Miyanaga F., Kawahara S., et al.: Dietary conjugated linoleic acid reciprocally modifies ketogenesis and lipid secretion by the rat liver. Lipids 1999, 34, 997-1000.
• 51. Satory D., Smith S.: Conjugated linoleic acid inhibits proliferation but stymulates lipid filling on murine 3T3-L1 preadipocytes. J. Nutr., 1999, 129, 92-97.
• 52. Sisk M., Azain M., Hausman D.: Effect of conjugated linoleic acid on fat pad weights and cellularity in Sprague-Dawley and Zucker rats. FASEB 1998, 12, A536.
• 53. Steinberg D., Parthsarathy S., Carew T.E., et al.: Beyond cholesterol. Modifications of low-density lipoprotein tha increase its atherogenicity. New Engl. J. Med., 1989, 320, 915-24.
• 54. West D., Delany J., Camet P, et al.: Efects of conjugated linoleic acid on body fat and energy metabolizm in the mouse. Am. J. Physiol., 1998, 275, R 667-72.
• 55. Yamasaki M., Mausho K., Mishima H., et al.: Dietary effect of conjugated linoleic acid on lipid levels in white adiposse tissue of Sprague-Dawley rats. Biosci. Biotechnol. Biochem., 1999, 63, 1104-6.